BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 15845914)

  • 21. Estrogen-replacement therapy in younger women with breast cancer.
    Theriault RL; Sellin RV
    J Natl Cancer Inst Monogr; 1994; (16):149-52. PubMed ID: 7999457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The menopause: benefits and risks of hormone replacement therapy.
    Gambrell RD
    Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441
    [No Abstract]   [Full Text] [Related]  

  • 23. Current trends in hormone replacement therapy.
    Khashoggi TY
    Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone therapy and risk of breast cancer.
    Chen FP
    Chang Gung Med J; 2009; 32(2):140-7. PubMed ID: 19403003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing menopause.
    Cutson TM; Meuleman E
    Am Fam Physician; 2000 Mar; 61(5):1391-400, 1405-6. PubMed ID: 10735345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Available medical choices for the management of menopause.
    Castelo-Branco C; Palacios S; Calaf J; Vázquez F; Lanchares JL
    Maturitas; 2005 Nov; 52 Suppl 1():S61-70. PubMed ID: 16213114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on hormone replacement therapy.
    Gambrell RD
    Am Fam Physician; 1992 Nov; 46(5 Suppl):87S-96S. PubMed ID: 1442475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The medical management of menopause: to treat or not to treat?
    Barlow DH
    Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O; Metsä-Heikkilä M
    Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Climacteric: concept, consequence and care.
    Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom KK
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S1-15. PubMed ID: 12188398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risks and benefits of long-term treatment with estrogens.
    Mack TM; Ross RK
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1811-20. PubMed ID: 2692147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis].
    Urano T
    Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and the menopause: a global overview.
    Barrett-Connor E
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():6-14. PubMed ID: 8499961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice.
    Genazzani AR; Monteleone P; Giannini A; Simoncini T
    Hum Reprod Update; 2021 Oct; 27(6):1115-1150. PubMed ID: 34432008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
    Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.